Female contraception over 40

Human Reproduction Update

Volumn 15, Issue 6, 2009, Pages 599-612

  Baird, D T ^a   Castelo Branco, C ^b   Collins, J ^c   Evers, J L H ^d   Glasier, A ^e   La Vecchia, C ^f   Leridon, H ^g   Mishell Jr , D R ^h   Wellings, K ⁱ   Arisi, E ^j   Benagiano, G ^k   Bitzer, J ^l   Crosignani, Pier Giorgio ^m   Diczfalusy, E ⁿ   Lanzone, A ^o   Skouby, S O ^p   Stock, G ^q   Volpe, A ^r  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF BARCELONA   (Spain)

^c MCMASTER UNIVERSITY   (Canada)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Family Planning and WW Services   (United Kingdom)

^f MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^g INSTITUT NATIONAL D'ÉTUDES DÉMOGRAPHIQUES   (France)

^h WOMEN S AND CHILDREN S HOSPITAL   (United States)

ⁱ LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^j Dipartimento Materno Infantile   (Italy)

^k SAPIENZA UNIVERSITY OF ROME   (Italy)

^l UNIVERSITY HOSPITAL BASEL   (Switzerland)

^m FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

ⁿ KAROLINSKA INSTITUTE   (Sweden)

^o FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^p UNIVERSITY OF COPENHAGEN   (Denmark)

^q Berlin Brandenburgische Akademie der Wissenschaften   (Germany)

^r UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

more..

Author keywords

Ageing; Contraception; Family planning; Premenopause; Sterilization

Indexed keywords

COPPER INTRAUTERINE DEVICE; DROSPIRENONE; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; LOW DOSE ORAL CONTRACEPTIVE; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; AGING; ARTERY THROMBOSIS; ARTICLE; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHROMOSOME ABERRATION; CLINICAL TRIAL; CONTRACEPTION; DOSE RESPONSE; ENDOCRINE FUNCTION; FAMILY PLANNING; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FEMALE SEXUAL DYSFUNCTION; FEMALE STERILITY; FEMALE STERILIZATION; HIGH RISK PREGNANCY; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LIVE BIRTH; LOW DRUG DOSE; MATERNAL MORTALITY; MENOPAUSAL SYNDROME; MENSTRUAL IRREGULARITY; PERINATAL MORTALITY; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEXUAL FUNCTION; SPONTANEOUS ABORTION; VENOUS THROMBOEMBOLISM; WOMEN'S HEALTH;

ADULT; AGE FACTORS; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; FERTILITY; HUMANS; INFANT, NEWBORN; MENOPAUSE; MIDDLE AGED; PREGNANCY;

EID: 70350000596     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmp020     Document Type: Article

References (93)

1. Addis IB, Van den Eeden SK, Wassel-Fyr CL, Vittinghoff E, Brown JS, Thom DH. Sexual activity and function in middle-aged and older women. Obstet Gynecol 2006;107:755-764.
2. Andersen AMN, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: Population based register linkage study. BMJ 2000; 320:1708-1712.
3. Baird DT, Mitchell A. Hormonal control of folliculogenesis: The key to successful reproduction. Ernst Schering Res Found Workshop 2002; 41:1-9.
4. Bajos N, Leridon H, Job-Spira N. Introduction (Contraception and abortion in France in the 2000s). Population-E 2004;59 347-356.
5. Baker TG. A quantitative and cytological study of germ cells inhuman ovaries. Proc R Soc Lond B Biol Sci 1963;158:417-433.
6. Beaumel C, Richet-Mastain L, Vatan M. La situation démographique en 2003. Mouvement de la population. Paris: INSEE (Résultat Société 41), 2005.
7. Beining RM, Dennis LK, Smith EM, Dokras A. Meta-analysis of intrauterine device use and risk of endometrial cancer. Ann Epidemiol 2008; 18:492-499.
8. Berrington A. Perpetual postponers? Women's, men's and couple's intentions and subsequent fertility behaviour. Popul Trends 2004; 117:9-19.
9. Bewley S, Davies M, Braude P. Which career first? BMJ 2005;331 588-589.
10. Bhathena RK, Guillebaud J. Contraception for the older woman: An update. Climacteric 2006;9:264-276.
11. Blümel JE, Castelo-Branco C, Binfa L, Aparicio R, Mamani L. A scheme of combined oral contraceptives for women over 40. Menopause 2001; 8:286-289.
12. Brooks L. The Tyranny of Choice. The Guardian, 2006. 2006 May 2nd. www.guardian.co.uk.
13. Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: Focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update 2007;13:559-565.
14. Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, Syverson CJ. Pregnancy-related mortality surveillance-United States, 1991-1999. MMWR Surveill Summ 2003;52:1-8.
15. Cleary-Goldman J, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock CH, Saade GR, Eddleman KA, Klugman S, Dugoff L et al. Impact of maternal age on obstetric outcome. Obstet Gynecol 2005; 105 983-990.
16. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: Collaborative reanalysis of data from 45 epidemiological studies including 23257 women with ovarian cancer and 87303 controls. Lancet 2008;371:303-314.
17. Collaborative Group on Hormonal Factor in Breast Cancer. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1996;347:1713-1727.
18. de Guibert-Lantoine C, Leridon H. Contraception in France. An assessment after 30 years of liberalization. Popul: An English Selection 1999;11:89-114.
19. De Vet A, Laven JSE, De Jong FH, Themmen APN, Fauser BCJM. Anti-Mullerian hormone serum levels: A putative marker forovarian ageing. Fertil Steril 2002;77:357-362.
20. Deeks AA, McCabe MP. Sexual function and the menopausal woman: The importance of age and partner's sexual functioning - Statistical Data Included. J Sex Res 2001; http://findarticles.com/p/articles/ mi_m2372/is_3_38/ai_82013893/pg_11?tag=artBody;coll.
21. Dennerstein L, Alexander JL, Kotz K. The menopause and sexual functioning: A review of the population-based studies. Annu Rev Sex Res 2003;14:64-82.
22. Dinger JC, Heineman LA, Kühl-Habich D. The safety of a drospirenone-containing oral contraceptive: Final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception 2007;75 344-354.
23. Dixon M, Margo M. The baby gap. In: Population Politics. UK: Institute for Public Policy Research, 2005, 71-912.
24. Dutch Central Bureau of Statistics CBS. 2006; http://www.cbs.nl.
25. ESHRE Capri Workshop Group. Hormonal contraception: What is new? Hum Reprod Update 2002;8:359-371.
26. ESHRE Capri Workshop Group. Diagnosis and management of the infertile couple: Missing information. Hum Reprod Update 2004; 10 295-307.
27. ESHRE Capri Workshop Group. Fertility and ageing. Hum Reprod Update 2005;11:261-276.
28. ESHRE Capri Workshop Group. Intrauterine devices and intrauterine systems. Hum Reprod Update 2008;14:197-208.
29. Faculty of Family Planning and Reproductive Health Care. FFPRHC Guidance (January 2005) contraception for women aged over 40 years. J Fam Plann Reprod Health Care 2005;31:51-63.
30. Ferenidou F, Kapoteli V, Moisidis K, Koutsogiannis I, Giakoumelos A, Hatzichristou D. Presence of a sexual problem may not affect women's satisfaction from their sexual function. J Sex Med 2008; 5 631-639.
31. Fernandez E, La Vecchia C, Balducci A, Chatenoud L, Franceschi S, Negri E. Oral contraceptives and colorectal cancer risk: A meta-analysis. Br J Cancer 2001;84:722-727.
32. Gallicchio L, Schilling C, Tomic D, Miller SR, Zacur H, Flaws JA. Correlates of sexual functioning among mid-life women. Climacteric 2007; 10:132-142.
33. Gambacciani M, Cappagli B, Lazzarini V, Ciaponi M, Fruzzetti F, Genazzani AR. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density. Maturitas 2006;54:176-180.
34. Gillan A. Britons Put Work and Fun Before Babies. The Guardian 2006, Tuesday May 2nd.
35. Glasier A, Gebbie A. Contraception for the older woman. Baillieres Clin Obstet Gynaecol 1996;10:121-138.
36. Gosden RG. Biology of Menopause: The Causes and Concerns of Ovarian Ageing. London: Academic Press Inc., 1985.
37. Gougeon A, Elochard R, Thalabard JC. Age-related changes of the population of human ovarian follicles: Increase in the disappearance rate of non-growing and early growing follicles in ageing women. Biol Reprod 1994;50:653-661.
38. Gracia CR, Freeman EW, Sammel MD, Lin H, Mogul M. Hormones and sexuality during transition to menopause. Obstet Gynecol 2007; 109 831-840.
39. Guay AT. Grand Master Lectures - Lecture 5 - Sexual dysfunction in the diabetic patient. Int J Impot Res 2001;13:S47-S50.
40. Hannaford PC, Selvaraj S, Elliott AM, Angus V, Iversen L, Lee AJ. Cancer risk among users of oral contraceptives: Cohort data from the Royal College of General Practitioner's oral contraception study. BMJ 2007; 335:651.
41. Heffner LJ. Advanced maternal age - how old is too old? N Engl J Med 2004;351:1927-1929.
42. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007;370:1609-1621.
43. Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet Gynecol 2004;104:727-733.
44. Joseph KS, Allen AC, Dodds L, Turner LA, Scott H, Liston R. The perinatal effects of delayed childbearing. Obstet Gynecol 2005; 105: 1410-1418.
45. Kaunitz AM. Clinical practice. Hormonal contraception in women of older reproductive age. N Engl J Med 2008;358:1262-1270.
46. Kemkes-Grottenhaler A. Postponing or rejecting parenthood ? Results of a survey among female academic professionals. J Biosoc Sci 2003; 35:213-226.
47. Kirkwood TBL. Ovarian ageing and the general biology of senescence. Maturitas 1998;30:105-111.
48. Klein KA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE, Soules MR. Decreased inhibin B secretion is associated with monotropic FSH rise in older ovulatory women; a study of serum and follicular fluid levels of climeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 1996;81:2742-2745.
49. Kuohung W, Borgatta L, Stubblefield P. Low-dose oral contraceptives and bone mineral density: An evidence-based analysis. Contraception 2000; 61:77-82.
50. Lader D, Hopkins G. Contraception and Sexual Health, 2007/08. Cardiff, UK: Office for National Statistics, 2003, 2008, 1-72; http://www.statistics.gov.uk (29 December 2008, date last accessed).
51. La Vecchia C. Oral contraceptives and ovarian cancer: An update, 1998-2004. Eur J Cancer Prev 2006;15:117-124.
52. La Vecchia C, Bosetti C. Oral contraceptives and cervical cancer: Public health implications. Eur J Cancer Prev 2003;12:1-2.
53. La Vecchia C, Bosetti C. Benefits and risks of oral contraceptives on cancer. Eur J Cancer Prev 2004;13:467-470.
54. La Vecchia C, Franceschi S. Third generation oral contraceptives and vascular risks. Eur J Public Health 2002;12:81-82.
55. Lambalk CB, De Koning CH, Braat DDM. The endocrinology of dizygotic twinning in the human. Mol Cell Endocrinol 1998;145: 97-102.
56. Lampic C, Skoog Svanberg A, Karlström P, Tydén T. Fertility awareness, intentions concerning childbearing, and attitudes towards parenthood among female and male academics. Hum Reprod 2006; 21 558-564.
57. Landgren BM, Collins A, Csemiczky G, Burger HG, Baksheev L, Robertson DM. Menopause transition: Annual changes in serum hormonal patternsover the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metab 2004; 89:2763-2769.
58. Leridon H. Demographic effects of the intoduction of steroid contraception in developed countries. Hum Reprod Update 2006; 12:603-616.
59. Leridon H. A new estimate of permanent sterility by age: Sterility defined as the inability to conceive. Popul Stud (Camb) 2008;62 15-24.
60. Leridon H, Slama R. The impact of a decline in fecundity and of pregnancy postponement on final number of children and demand for assisted reproduction technology. Hum Reprod 2008;23: 1312-1319.
61. Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007;357:762-774.
62. Maheshwari A, Porter M, Shetty A, Siladitya Bhattacharya S. Women's awareness and perceptions of delay in childbearing. Fertil Steril 2008; 90:1036-1042.
63. Martin K, Wu Z. Contraceptive use in Canada: 1984-1995. Fam Plann Perspect 2000;32:65-73.
64. McCall-Hosenfeld JS, Freund KM, Legault C, Jaramillo SA, Cochrane BB, Manson JE, Wenger NK, Eaton CB, McNeeley SG, Rodriguez BL et al. Sexual satisfaction and cardiovascular disease: The Women's Health Initiative. Am J Med 2008;121:295-301.
65. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000;21:200-214.
66. Metcalf MG, Donald RA, Livesey JH. Pituitary-ovarian function before, during and after the menopause: A longitudinal study. Clin Endocrinol (Oxf) 1982;17:489-494.
67. Michaëlsson K, Baron JA, Farahmand BY, Persson I, Ljunghall S. Oral-contraceptive use and risk of hip fracture: A case-control study. Lancet 1999;353:1481-1484.
68. Moore EE, Hawes SE, Scholes D, Boyko EJ, Hughes JP, Fihn SD. Sexual intercourse and risk of symptomatic urinary tract infection in post-menopausal women. J Gen Intern Med 2008;23:595-599.
69. Morris JK, De VC, Mutton DE, Alberman E. Risk of a Down syndrome live birth in women 45 years of age and older. Prenat Diagn 2005; 25 275-278.
70. Mosher W. Contraceptive practice in the United States, 1982-1988. Fam Plann Perspect 1990;22:198-205.
71. Office for National Statistics. For the First Time Women in Early 30s have Higher Fertility Rates than Women in Late 20s. London: TSO, 2008. Available at. www.statistics.gov.uk/downloads/theme_population/ FM1_32/FM1no32pdf.
72. Office for National Statistics UK. Living in Britain. Results of the 2002 General Household Survey. Titchfield: ONS, 2004.
73. Office of Population Censuses and Surveys UK. General Household Survey 1993. London: HMSO, 1995.
74. Proudfoot S, Wellings K, Glasier A. Analysis why nulliparous women over 33 wish to use contraception. Contraception 2009;79:98-104.
75. Robinson GE, Garner DM, Gare DJ, Crawford B. Psychological adaptation to pregnancy in childless women more than 35 years of age. Am J Obstet Gynecol 1987;156:328-333.
76. Sherman BM,West JH, Korenman SG. The menopausal transition: Analysis of LH, FSH, estradiol and progesterone concentrations during the menstrual cycles of older women. J Clin Endocrinol Metab 1976; 42 629-636.
77. Sivin I. Utility and drawbacks of continuous use of a copper T IUD for 20 years. Contraception 2007;75:S70-S75.
78. Smallwood S, Jeffries J. Family building intentions in England and Wales: Trends, outcomes and interpretations. Popul Trends 2003; 112:15-28.
79. Sowers MR, Eyvazzadeh AD, McConnell D, Yosef M, Jannausch ML, Zhang D, Harlow S, Randolph JF Jr. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008;93:3478-3483.
80. Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, Devroey P, Liebaers I, Van Steirteghem A. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: A prospective randomized controlled trial. Hum Reprod 2004; 19 2849-2858.
81. Tough S, Benzies K, Fraser-Lee N, Newburn-Cook C. Factors influencing childbearing decisions and knowledge of perinatal risks among Canadian men and women. Matern Child Health J 2007;11: 189-198.
82. Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1967;12 77-126.
83. Trussell J. Contraceptive failure in the United States. Contraception 2004; 70:89-96.
84. UK Central Health Statistics. 2006, http://www.statistics.gov.uk.
85. United Nations Population Division. World Population Prospects. The 2006 Revision (Vol. II). New York: United Nations, 2007.
86. United Nations Economic Commission for Europe. Fertility and Family Surveys. National Reports (various countries and years).
87. U.S. Department of Health and Human Services. Fertility, Family Planning and Reproductive Health of U.S. Women: Data from the 2002 National Survey of Family Growth. Hyattsville: DHHS, 2006.
88. van Noord-Zaadstra BM, Looman CW, Alsbach H, Habbema JDF, te Velde ER, Karbaat J. Delaying childbearing: Effect of age on fecundity and outcome of pregnancy. Br Med J 1991;302:1361-1365.
89. van Rooij IAJ, Broekmans FJM, Te Velde ER, Fauser BCJM, Bancsi LFJMM, De Jong FH, Themmen APN. Serum anti-Müllerian hormone levels: A novel measure of ovarian reserve. Hum Reprod 2000;17:3065-3071.
90. Wallace WH, Kelsey TW. Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography. Hum Reprod 2004;19:1612-1617.
91. Webb R, Campbell BK. Development of the dominant follicle: Mechanisms of selection and maintenance of oocyte quality. Soc Reprod Fertil Suppl 2007;64:141-163.
92. World Health Organization (WHO). Medical Eligibility Criteria for Contraceptive Use, 3rd edn. Geneva, Switzerland: WHO, 2004.
93. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1997; 349 1202-1209.